Position in SVRA
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$3,225,857
+$212,146 QoQ
Shares Held
534,968
-36.6% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Derivatives in SVRA
reported options exposure · as of Jun 30, 2024CallValue
$311,116
CallShares
77,200
PutValue
$1,209,000
PutShares
300,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in SVRA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3,225,857 | 534,968 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,013,711 | 844,177 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $144,618 | 52,209 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,480,547 | 482,263 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,190,015 | 280,664 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $118,542 | 29,415 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $1,209,000 | 300,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $311,116 | 77,200 | Call | Sole | 2024-08-14 | |
| 2023-12-31 | $4,901,639 | 1,042,902 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $1,675,865 | 859,418 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $282,766 | 182,430 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $175,926 | 113,501 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $237,597 | 156,314 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $182,379 | 139,221 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $481,599 | 388,387 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $476,044 | 344,960 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,323,183 | 1,954,814 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,038,681 | 499,366 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $1,398,877 | 561,798 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,403,281 | 661,925 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||